Natalizumab: state of the art and open questions.
Department of Neurology, INSPE, IRCCS H San Raffaele Hospital, Via Olgettina 48, 20132, Milan, Italy. comi.giancarlo@hsr.it
G
G
Comi
D000818:Animals; D061067:Antibodies, Monoclonal, Humanized / Q000009:adverse effects / Q000627:therapeutic use*; D004342:Drug Hypersensitivity / Q000209:etiology; D005221:Fatigue / Q000139:chemically induced; D006801:Humans; D020529:Multiple Sclerosis, Relapsing-Remitting / Q000188:drug therapy* / Q000473:pathology; D000069442:Natalizumab
D061067:Antibodies, Monoclonal, Humanized; D000069442:Natalizumab